AN OBSERVATIONAL STUDY OF OCRELIZUMAB TREATED PATIENTS WITH MULTIPLE SCLEROSIS TO DETERMINE THE INCIDENCE AND MORTALITY RATES OF BREAST CANCER AND ALL MALIGNANCIES (VERISMO STUDY)
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Screening
Locations
University of Colorado Hospital
Study ID
Protocol Number: 19-1600
More information available at ClinicalTrials.gov: NCT00000000
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers